Premier GPO Renews Partnership with Fagron Sterile Services US
Fagron is excited to share our continued partnership with Premier and the renewal of our GPO contract. This agreement covers Fagron's entire portfolio of high-quality, ready-to-administer compounded sterile preparations with application in acute and non-acute facilities.
"We are proud to continue our partnership with Premier and their member organizations, bringing critical and highly utilized medications with unique presentations and containers to help improve patient care,” said MJ DeMott, Sr Director of National Accounts.
For 20 years, Fagron Sterile Services US has been trusted by thousands of patient-focused healthcare facilities to deliver a reliable supply of high-quality sterile medications – produced through state-of-the-art cGMP compliant operations. FSS' DEA & FDA registered and inspected 503B outsourcing solutions support millions of patients across North America each year.
About Fagron Sterile Services US
Fagron Sterile Services US (FSS), a top-tier DEA and FDA-registered 503B Outsourcing Provider, produces reliable supply of high-quality sterile medications with cGMP compliant operations to patient-focused healthcare facilities across North America.
FSS' team boasts operational and regulatory expertise in pharmaceutical manufacturing and repackaging while leveraging industry-leading automation, advanced environmental monitoring, and sophisticated in-house quality testing labs. Batches are validated to support proper Beyond-Use Dating (BUD) and only released after successful sterility, particulate matter, and potency testing are complete.
FSS offers a broad product portfolio across Critical Care, Ophthalmics, Pain Management, and other Specialty Presentations and holds Integrated Delivery Network (IDN) agreements within all major GPOs.
Sign up for our e-mail updates to get the latest in product releases, customer notifications, and company news.Sign Up Now